UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000045780
Receipt No. R000052266
Scientific Title Acute effect of L-arginine supplementation on fat and carbohydrate metabolism before, during, and after endurance exercise in athletes
Date of disclosure of the study information 2021/12/01
Last modified on 2021/10/17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Mrs. Rezaee
Acronym Mrs. Rezaee
Scientific Title Acute effect of L-arginine supplementation on fat and carbohydrate metabolism before, during, and after endurance exercise in athletes
Scientific Title:Acronym Acute effect of L-arginine supplementation on fat and carbohydrate metabolism during endurance exercise in athletes
Region
Asia(except Japan)

Condition
Condition in progress
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 evaluate the acute effect of L-arginine supplementation on fat and carbohydrate metabolism before, during, and after endurance exercise in athletes
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes : Acute L-arginine supplementation increased maximal oxygen consumption, maximal heart rate, and prolonged fatigue during progressive exercise. Acute use of L-arginine supplementation also reduced maximal fat oxidation after exercise, increased maximal carbohydrate oxidation, and increased respiratory exchange ratio after progressive exercise. In addition, acute L-arginine supplementation increased blood glucose and glycerol concentrations
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Educational,Counseling,Training
Type of intervention
Other
Interventions/Control_1 6 g of Al-arginine supplement
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit
20 years-old >=
Gender Male
Key inclusion criteria 1Having calendar age in the range of 16 - 20 years
Having a minimum of five years of football playing a regular basis
lack of acute respiratory complications, asthma, and any disease that is considered harmful to the physician according to the physician
Key exclusion criteria -1having any symptoms of headaches, dizziness, and feeling of weakness while testing
2- Failure to complete the test period
3- Having a sensitivity to the use of Al -Arginine
Target sample size 12

Research contact person
Name of lead principal investigator
1st name Adel
Middle name
Last name Donyaee
Organization Shahrood University of technology
Division name Department of Physical Education and Sport Sciences, School of Physical Education and Sport Sciences
Zip code 1346638387
Address Shahrood, 7tir square,
TEL 00989153350749
Email adelldonyai@yahoo.com

Public contact
Name of contact person
1st name Adel
Middle name
Last name Donyaee
Organization Shahrood University of Technology
Division name Department of Physical Education and Sport Sciences, School of Physical Education and Sport Sciences
Zip code 1346638387
Address Shahrood, 7tir square,
TEL 00989153350749
Homepage URL
Email adelldonyai@yahoo.com

Sponsor
Institute Shahrood university of technology
Institute
Department

Funding Source
Organization Shahrooduniversity of technology
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Shahrood University of Technology
Address Shahrood, 7tir square,
Tel 00989153350749
Email adelldonyai@yahoo.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 12 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2021 Year 02 Month 01 Day
Date of IRB
2021 Year 03 Month 01 Day
Anticipated trial start date
2021 Year 04 Month 01 Day
Last follow-up date
2021 Year 04 Month 15 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 10 Month 17 Day
Last modified on
2021 Year 10 Month 17 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052266

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.